14th World Congress for Hair Research (WCHR 2026)

SEOUL, SOUTH KOREA / COLOGNE, GERMANY – niostem is honored to announce that Dr. Carlos Chacón-Martínez, co-founder and world-renowned expert in regenerative medicine, has been invited to present at the 14th World Congress for Hair Research (WCHR 2026).

Taking place in the vibrant city of Seoul, the WCHR is the global pinnacle of hair science, bringing together the world’s leading dermatologists, hair biologists, and regenerative medicine pioneers. Dr. Chacón-Martínez will take the stage to present the final, validated data from niostem’s most rigorous clinical trial to date.

The Gold Standard of Evidence The presentation will focus on the results of a double-blind, randomized, placebo-controlled trial—the "gold standard" of medical testing—conducted by the independent German research institute, Dermatest. The study monitored 80 participants over six months to evaluate the efficacy of niostem’s Stem Cell Reactivation Technology.

Key Clinical Highlights to be Presented:

  • Significant Density Increase: Participants using the active niostem device saw a 20.8% increase in total hair density after six months, compared to a 2.2% decrease in the placebo group.

  • Terminal Hair Growth: Most notably, thick, cosmetically relevant terminal hairs increased by 25.4%, providing a visible and statistically significant transformation.

  • Rapid Results: Significant separation from the placebo group was observed as early as the 3-month mark.

  • Female Pattern Hair Loss: Dr. Chacón-Martínez will also touch upon promising pilot data showing a 16.5% density increase in women, paving the way for expanded future trials.

A Vision for Non-Invasive Regeneration "Being invited to Seoul for the WCHR 2026 is a testament to the scientific rigor we apply at niostem," says Dr. Chacón-Martínez. "We aren't just presenting a product; we are presenting a validated shift in how pattern baldness can be managed. By using the same rigorous testing methodology required for new medicines, we have proven that our non-invasive technology effectively reactivates hair stem cells to deliver life-changing results without side effects."

The niostem device represents a departure from traditional chemical or surgical interventions, leveraging low-level electrical stimulation to tap into the body’s natural regenerative capabilities.

About Dr. Carlos Chacón-Martínez Dr. Chacón-Martínez is a leading figure in the field of hair stem cell research. With a background in regenerative medicine, he co-founded niostem to bridge the gap between complex laboratory science and accessible, at-home technology for those suffering from hair loss.

About niostem niostem is a German-based deep-tech startup dedicated to reversing hair loss through bio-electrical stimulation. For more information on the technology and to view our latest clinical whitepapers, visit www.niostem.com.

Read the Full Clinical Summary and Explore the niostem Technology